Royce & Associates’s PRA Health Sciences, Inc. PRAH Stock Holding History

Royce & Associates’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-9,949	Closed	-$1.01M	–	1055
2020 Q3	$1.01M	Hold	9,949	–	–	0.01%	778
2020 Q2	$968K	Hold	9,949	–	–	0.01%	791
2020 Q1	$826K	Hold	9,949	–	–	0.01%	765
2019 Q4	$1.11M	Buy	+9,949	New	+$1.02M	0.01%	795
2018 Q4	–	Sell	-28,836	Closed	-$3.18M	–	1223
2018 Q3	$3.18M	Sell	28,836 -45,000	-61%	-$4.69M	0.02%	712
2018 Q2	$6.89M	Buy	73,836 +13,500	+22%	+$1.16M	0.05%	494
2018 Q1	$5M	Buy	60,336 +2,500	+4%	+$222K	0.04%	570
2017 Q4	$5.27M	Buy	57,836 +4,636	+9%	+$386K	0.04%	575
2017 Q3	$4.05M	Hold	53,200	–	–	0.03%	639
2017 Q2	$3.99M	Buy	53,200 +25,000	+89%	+$1.73M	0.03%	658
2017 Q1	$1.84M	Buy	+28,200	New	+$1.66M	0.01%	884

Other funds holding PRAH

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NIPH

NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Royce & Associates's PRAH Position: Q4 2020 in Review

Royce & Associates sold out of PRA Health Sciences, Inc. (PRAH) in Q4 2020, closing a stake of 9,949 shares — an estimated $1.01M sold.

Royce & Associates first reported a position in PRAH in Q1 2017 and held it in 11 quarters. The position peaked at $6.89M in Q2 2018. 289 funds tracked by Wall St. Rank hold PRAH as of Q4 2020.

Royce & Associates reported no remaining PRA Health Sciences, Inc. position as of Q4 2020 after selling out during the quarter.
Royce & Associates sold 9,949 PRA Health Sciences, Inc. shares in Q4 2020, an estimated $1.01M.
Royce & Associates first reported a position in PRA Health Sciences, Inc. in Q1 2017 and held it in 11 quarters.
Royce & Associates's PRA Health Sciences, Inc. position peaked at $6.89M in Q2 2018.
289 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2020.

Based on Royce & Associates's 13F filing for Q4 2020, filed 8 Feb 2021.